Endometriosis: A Comprehensive Overview

100%

ENDOMETRIOSIS

Endometriosis is a common benign gynecological disease affecting women of reproductive age group. It causes pelvic pain and infertility.

Endometriosis is defined as the presence of functional endometrium (both endometrial glands and stroma) outside the uterus. It was described for the first time by von Rokitansky in eighteen sixty.

DEFINITION

Prevalence: The prevalence varies for five to twenty percent (average ten percent) in women of reproductive age group but is much higher, being thirty percent, in women with infertility and fifteen to thirty percent in women with chronic pelvic pain. Incidence seems to be rising probably due to more use of laparoscopy which detects early cases too.

ETIOLOGY

SITES (ANATOMICAL LOCATIONS) OF ENDOMETRIOSIS

PREDISPOSING (RISK) FACTORS FOR ENDOMETRIOSIS

Endometriosis and Adenomyosis

PATHOLOGY

Endometriosis and Adenomyosis

HISTOLOGICAL (MICROSCOPIC) APPEARANCE OF ENDOMETRIOSIS

MALIGNANT CHANGE IN ENDOMETRIOSIS

Section six: Benign and Promalignant Lesions in Gynecology

CLINICAL FEATURES OF ENDOMETRIOSIS

Symptoms

CAUSES OF PAIN IN ENDOMETRIOSIS

Menstrual symptoms

AUSES OF INFERTILITY IN

Endometriosis and Adenomyosis

DIFFERENTIAL DIAGNOSIS

Section number Bpnigh and Premalignant Lesions in Gynecology

Nine Gastrointestinal conditions

INVESTIGATIONS

Two. Diagnostic imaging

Table twenty-five point two: Various investigations for diagnosis of endometriosis

Endometriosis and Adenomyosis

CLASSIFICATION AND STAGING OF ENDOMETRIOSIS

One. rASRM Classification nineteen ninety-seven (Revised American Society for Reproductive Medicine Classification)

Endometriosis and Adenoryenis-

AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE REVISED CLASSIFICATION OF ENDOMETRIOSIS (nineteen ninety-seven)

Section six: Benign and Premalignant Lesions in Gynecology

Three. The Endometriosis Fertility Index

, TREATMENT

Endometriosis and Adenomyosis

(i) Nonsteroidal anti-inflammatory drugs

Side effects:

GnRH agonists: Their use causes pituitary desensitization and inhibition of ovarian steroidogenesis.

(a) Goserelin three point six milligrams subcutaneously monthly (or ten point eight milligrams three monthly)

Side effects

Dose: Elagolix - Low dose (one hundred fifty milligrams per day) and high dose (two hundred milligrams per day)

Side effects

(vii) Selective progesterone receptor modulators (SPRMs): These drugs bind to progesterone

Superficial Endometriosis

Surgery for Ovarian Endometrioma

Surgical treatment

SURGICAL TREATMENT OF DEEP INTRATING ENDOMETRIOSIS AND ADVANCED DISEASE

RECURRENCE OF ENDOMETRIOSIS

PRE AND POSTOPERATIVE HORMONE REPLACEMENT

TREATMENT OF INFERTILITY IN ENDOMETRIOSIS

Endometriosis and Adenomyosis

ENDOMETRIOSIS IN ADOLESCENCE (ESHRE twenty twenty-two)

Section six: Benign and Premalignant Lesions in Gynecology

SCAR ENDOMETRIOSIS (Figure twenty-five point eight)

NEW ADVANCES

ADENOMYOSIS

Endometriosis and Adenomyosis

PATHOLOGY

Section six: Benign and Premalignant Lesions in Gynecology

CLINICAL FEATURES

Signs

INVESTIGATIONS

MANAGEMENT

Medical Treatment

SURGICAL TREATMENT

INTERVENTIONAL TECHNIQUES

Overview

This document explores the complex condition of endometriosis, including its definition, prevalence, and various theories regarding its etiology. It discusses associated risk factors and the pathological classifications of endometriosis and highlights the significance of accurate diagnosis and management.

Key Points

1Endometriosis is a common condition affecting women of reproductive age, causing pelvic pain and infertility
2The prevalence of endometriosis is higher in women with infertility and chronic pelvic pain
3Multiple theories exist regarding the etiology of endometriosis, including retrograde menstruation and coelomic metaplasia
4Diagnosis typically requires laparoscopy, as it may not be visible through imaging
5Treatment options vary based on severity and symptoms, with surgical intervention often necessary for severe cases.

Details

Category: Health and Medicine

PDF
Neurological, Musculoskeletal, and Otologic Disorders: Pathophysiology and Key Interventions
This document provides an in-depth overview of various neurological, musculoskeletal, and otologic disorders, detailing their pathophysiology, key symptoms, and critical interventions for management and treatment. It serves as a comprehensive guide for healthcare professionals.
PDF
heart disease
This chapter discusses the physiological changes and risks associated with cardiac disease during pregnancy, providing crucial insights into diagnosis, classification, maternal and fetal effects, and management strategies for patients with heart conditions.
PDF
Lymphatic Drainage and Innervation of Female Genital Organs
This document discusses the lymphatic drainage and nerve supply of the female pelvis and genital organs, detailing the pathways and importance of lymph nodes in the context of genital malignancies and surgical procedures.
PDF
poly oligo
This document provides a comprehensive overview of abnormalities related to membranes and amniotic fluid during pregnancy, including conditions such as polyhydramnios and their clinical implications, diagnosis, and management.
PDF
Injuries to Birth Canal
This document discusses maternal injuries related to childbirth, including perineal tears and genital trauma, their management, prevention strategies, and implications for future deliveries.